Results 121 to 130 of about 17,534 (188)

Association of Glucagon-like Peptide-1 Receptor Agonist Use with Stroke and Mortality Outcomes in Asymptomatic Intracranial Atherosclerotic Disease: Propensity Score-Matched Real-World Analysis. [PDF]

Neurol Int
Rai P, Mandel D, Bathla G, Dhaduk V, Rajeev R, Kakadiya J, Chen HA, Salim HA, Azzam AY, Essibayi MA, Connolly B, Buzzelli M, Yedavalli VS, Khan M, Dmytriw AA, Altschul DJ, McIntyre MK, Colasurdo M, Malhotra A, Gandhi D, Lakhani DA.   +20 more
europepmc   +1 more source

Drug-eluting stents versus bare-metal stents in the treatment of drug-refractory intracranial atherosclerotic disease: a retrospective single-center comparison. [PDF]

CVIR Endovasc
von Gottberg P, Henkes H, Hajiyev K, Forsting M, Filioglo A, Bäzner H, Khanafer A.   +6 more
europepmc   +1 more source

Preoperative Neurological Changes on Outcomes in Large-Vessel Occlusion Due to Intracranial Atherosclerotic Disease. [PDF]

Neurosurg Pract
Yoshimoto T, Tanaka K, Koge J, Uchida K, Imamura H, Toyoda K, Yamagami H, Yamagami H, Sakai N, Sakai N, Shirakawa M, Beppu M, Matsumaru Y, Matsumoto Y, Todo K, Hayakawa M, Shindo S, Morimoto M, Takeuchi M, Ikeda H, Ishihara H, Kakita H, Sano T, Araki H, Nomura T, Sakakibara F, Yoshimura S.   +26 more
europepmc   +1 more source

Comparative safety of stent retriever designs for intracranial atherosclerotic disease related large vessel occlusion using agarose models. [PDF]

Sci Rep
Imaoka Y, Mikami K, Fuchita A, Ikeda S, Ren N, Watanabe S, Abe S, Yoshie T, Namitome S, Kobashi S, Imamura H, Iihara K.   +11 more
europepmc   +1 more source

Recurrent Intracranial Atherosclerotic Disease (ICAD)-Large-Vessel Occlusion (LVO) in Acute Lymphoblastic Leukemia Treated by Rescue Angioplasty: A Case Report. [PDF]

Cureus
Yoshihara R, Ishizuka T, Okuma M, Hatayama T, Nakamura H.   +4 more
europepmc   +1 more source

Delayed Diagnosis of Myxedema Coma in a Patient With Concurrent Severe Intracranial Atherosclerotic Disease. [PDF]

Cureus
Tolaymat A, Mitchell G.
europepmc   +1 more source

Risk factors of restenosis after paclitaxel-coated balloon treatment in symptomatic intracranial atherosclerotic disease. [PDF]

Sci Rep
Chen Y, Dong K, Song Y, Sun L, Zheng M, Yin H, Zhang J, Wang W, Meng Y, Li W, He X, Zhao W, Han J.   +12 more
europepmc   +1 more source

Stroke Mechanisms in Intracranial Atherosclerotic Disease: A Modified Classification System and Clinical Implications. [PDF]

Transl Stroke Res
Li S, Tian X, Feng X, Ip B, Ip HL, Abrigo J, Zheng L, Liu Y, Liu Y, Li Z, Liang T, Ma KKY, Fan FSY, Ma SH, Fang H, Song B, Xu Y, Leung H, Soo YOY, Mok VCT, Wong KS, Leng X, Leung TWH.   +22 more
europepmc   +1 more source

Significant miRNAs as Potential Biomarkers to Differentiate Moyamoya Disease From Intracranial Atherosclerotic Disease. [PDF]

J Clin Neurol
Lee H, Hwang M, Kwon HS, Kim YS, Kim HY, Jeong S, Noh KC, Choi HY, Woo HG, Heo SH, Koh SH, Chang DI.   +11 more
europepmc   +1 more source

Association between ischemic stroke and hyperintense plaques detected by high-resolution vessel wall MRI in Japanese patients with intracranial atherosclerotic disease. [PDF]

Front Stroke
Takayama N, Maki T, Fushimi Y, Okawa M, Mineharu Y, Yamada K, Yang T, Yamamoto Y, Suzuki K, Yasuda K, Grinstead J, Ahn S, Matsumoto R, Arakawa Y, Yoshida K.   +14 more
europepmc   +1 more source